{
  "DOI": "10.1007/s10689-018-0089-z",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-018-0089-z",
  "alternative-id": [
    "89"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "30 May 2018"
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Menko",
      "given": "Fred H",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "ter Stege",
      "given": "Jacqueline A",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van der Kolk",
      "given": "Lizet E",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jeanson",
      "given": "Kiki N",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Schats",
      "given": "Winnie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Moha",
      "given": "Daoud Ait",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bleiker",
      "given": "Eveline M A",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        5,
        30
      ]
    ],
    "date-time": "2018-05-30T08:23:14Z",
    "timestamp": 1527668594000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        9,
        24
      ]
    ],
    "date-time": "2019-09-24T06:38:16Z",
    "timestamp": 1569307096000
  },
  "funder": [
    {
      "DOI": "10.13039/501100004622",
      "award": [
        "NKI 2014-6944"
      ],
      "doi-asserted-by": "publisher",
      "name": "KWF Kankerbestrijding"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        22
      ]
    ],
    "date-time": "2024-04-22T09:10:44Z",
    "timestamp": 1713777044463
  },
  "is-referenced-by-count": 65,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2018,
        5,
        30
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2019,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            5,
            30
          ]
        ],
        "date-time": "2018-05-30T00:00:00Z",
        "timestamp": 1527638400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-018-0089-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-0089-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-0089-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "127-135",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2018,
        5,
        30
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        5,
        30
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJMra0802968",
      "author": "WD Foulkes",
      "doi-asserted-by": "publisher",
      "first-page": "2143",
      "journal-title": "N Engl J Med",
      "key": "89_CR1",
      "unstructured": "Foulkes WD (2008) Inherited susceptibility to common cancers. N Engl J Med 359:2143–2153",
      "volume": "359",
      "year": "2008"
    },
    {
      "DOI": "10.1038/onc.2015.181",
      "author": "L Golmard",
      "doi-asserted-by": "publisher",
      "first-page": "1324",
      "journal-title": "Oncogene",
      "key": "89_CR2",
      "unstructured": "Golmard L, Delnatte C, Laugé A, Moncoutier V, Lefol C, Abidallah K et al (2016) Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations. Oncogene 35:1324–1327",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.1136/jmedgenet-2011-100082",
      "author": "AK Win",
      "doi-asserted-by": "publisher",
      "first-page": "530",
      "journal-title": "J Med Genet",
      "key": "89_CR3",
      "unstructured": "Win AK, Jenkins MA, Buchanan DD, Clendenning M, Young JP, Giles GG et al (2011) Determining the frequency of de novo germline mutations in DNA mismatch repair genes. J Med Genet 48:530–534",
      "volume": "48",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10689-005-2581-5",
      "author": "B Godard",
      "doi-asserted-by": "publisher",
      "first-page": "103",
      "journal-title": "Fam Cancer",
      "key": "89_CR4",
      "unstructured": "Godard B, Hurlimann T, Letendre M, Égalité N, INHERIT BRCAs (2006) Guidelines for disclosing genetic information to family members: from development to use. Fam Cancer 5:103–116",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201822",
      "author": "LE Forrest",
      "doi-asserted-by": "publisher",
      "first-page": "612",
      "journal-title": "Eur J Hum Genet",
      "key": "89_CR5",
      "unstructured": "Forrest LE, Delatycki MB, Skene L, Aitken M (2007) Communicating genetic information in families—a review of guidelines and position papers. Eur J Hum Genet 15:612–618",
      "volume": "15",
      "year": "2007"
    },
    {
      "DOI": "10.1038/gim.2015.72",
      "author": "S Dheensa",
      "doi-asserted-by": "publisher",
      "first-page": "290",
      "journal-title": "Genet Med",
      "key": "89_CR6",
      "unstructured": "Dheensa S, Fenwick A, Shkedi-Rafid S, Crawford G, Lucassen A (2016) Health-care professionals’ responsibility to patients’ relatives in genetic medicine: a systematic review and synthesis of empirical research. Genet Med 18:290–301",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10689-017-9970-4",
      "author": "B Derbez",
      "doi-asserted-by": "publisher",
      "first-page": "447",
      "journal-title": "Fam Cancer",
      "key": "89_CR7",
      "unstructured": "Derbez B, de Pauw A, Stoppa-Lyonnet D, de Montgolfier S (2017) Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics. Fam Cancer 16:447–457",
      "volume": "16",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10689-013-9636-9",
      "author": "FH Menko",
      "doi-asserted-by": "publisher",
      "first-page": "319",
      "journal-title": "Fam Cancer",
      "key": "89_CR8",
      "unstructured": "Menko FH, Aalfs CM, Henneman L, Stol Y, Wijdenes M, Otten E et al (2013) Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer 12:319–324",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1136/bmj.k1409",
      "author": "A Lucassen",
      "doi-asserted-by": "publisher",
      "journal-title": "BMJ",
      "key": "89_CR9",
      "unstructured": "Lucassen A, Gilbar R (2018) Alerting relatives about heritable risks: the limits of confidentiality. BMJ. \n                    https://doi.org/10.1136/bmj.k1409",
      "year": "2018"
    },
    {
      "DOI": "10.1002/ajmg.10110",
      "author": "C Hughes",
      "doi-asserted-by": "publisher",
      "first-page": "143",
      "journal-title": "Am J Med Genet",
      "key": "89_CR10",
      "unstructured": "Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S et al (2002) All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 107:143–150",
      "volume": "107",
      "year": "2002"
    },
    {
      "DOI": "10.1089/109065703322537241",
      "author": "C Blandy",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "journal-title": "Genet Test",
      "key": "89_CR11",
      "unstructured": "Blandy C, Chabal F, Stoppa-Lyonnet D, Julian-Reynier C (2003) Testing participation in BRCA1/2-positive families: initiator role of index cases. Genet Test 7:225–233",
      "volume": "7",
      "year": "2003"
    },
    {
      "DOI": "10.1002/ajmg.a.10868",
      "author": "E Claes",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Am J Med Genet",
      "key": "89_CR12",
      "unstructured": "Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E (2003) Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet 116A:11–19",
      "volume": "116A",
      "year": "2003"
    },
    {
      "DOI": "10.1097/01.GIM.0000144014.91237.A1",
      "author": "B McGivern",
      "doi-asserted-by": "publisher",
      "first-page": "503",
      "journal-title": "Genet Med",
      "key": "89_CR13",
      "unstructured": "McGivern B, Everett J, Yager GG, Baumiller RC, Hafertepen A, Saal HM (2004) Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med 6:503–509",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1002/ajmg.c.10003",
      "author": "J Wagner Costalas",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Am J Med Genet",
      "key": "89_CR14",
      "unstructured": "Wagner Costalas J, Itzen M, Malick J, Babb JS, Bove B, Godwin AK et al (2003) Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. Am J Med Genet 119C:11–18",
      "volume": "119C",
      "year": "2003"
    },
    {
      "DOI": "10.1136/jmg.2003.011353",
      "author": "E Sermijn",
      "doi-asserted-by": "publisher",
      "first-page": "e23",
      "journal-title": "J Med Genet",
      "key": "89_CR15",
      "unstructured": "Sermijn E, Goelen G, Teugels E, Kaufman L, Bonduelle M, Neyns B et al (2004) The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. J Med Genet 41:e23",
      "volume": "41",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10689-004-7991-2",
      "author": "K Landsbergen",
      "doi-asserted-by": "publisher",
      "first-page": "115",
      "journal-title": "Fam Cancer",
      "key": "89_CR16",
      "unstructured": "Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N (2005) Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Fam Cancer 4:115–119",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.1200/JCO.2005.01.7541",
      "author": "AF Patenaude",
      "doi-asserted-by": "publisher",
      "first-page": "700",
      "journal-title": "J Clin Oncol",
      "key": "89_CR17",
      "unstructured": "Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE (2006) Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 24:700–706",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1089/gte.2007.0037",
      "author": "E Finlay",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "journal-title": "Genet Test",
      "key": "89_CR18",
      "unstructured": "Finlay E, Stopfer JE, Burlingame E, Goldfeder Evans K, Nathanson KL, Weber BL et al (2008) Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genet Test 12:81–91",
      "volume": "12",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-10-0325",
      "author": "EL Cheung",
      "doi-asserted-by": "publisher",
      "first-page": "2211",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "89_CR19",
      "unstructured": "Cheung EL, Olson AD, Yu TM, Han PZ, Beattie MS (2010) Communication of BRCA results and family testing in 1,103 high-risk women. Cancer Epidemiol Biomarkers Prev 19:2211–2219",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10897-013-9592-4",
      "author": "J Fehniger",
      "doi-asserted-by": "publisher",
      "first-page": "603",
      "journal-title": "J Genet Couns",
      "key": "89_CR20",
      "unstructured": "Fehniger J, Lin F, Beattie MS, Joseph G, Kaplan C (2013) Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers. J Genet Couns 22:603–612",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10897-013-9656-5",
      "author": "D Kegelaers",
      "doi-asserted-by": "publisher",
      "first-page": "254",
      "journal-title": "J Genet Couns",
      "key": "89_CR21",
      "unstructured": "Kegelaers D, Merckx W, Odeurs P, van den Ende J, Blaumeiser B (2014) Disclosure pattern and follow-up after the molecular diagnosis of BRCA/CHEK2 mutations. J Genet Couns 23:254–261",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2017.52",
      "author": "E Healey",
      "doi-asserted-by": "publisher",
      "first-page": "1323",
      "journal-title": "Genet Med",
      "key": "89_CR22",
      "unstructured": "Healey E, Taylor N, Greening S, Wakefield CE, Warwick L, Williams R et al (2017) Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families. Genet Med 19:1323–1331",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.cgh.2007.12.014",
      "author": "EM Stoffel",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "journal-title": "Clin Gastroenterol Hepatol",
      "key": "89_CR23",
      "unstructured": "Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P et al (2008) Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 6:333–338",
      "volume": "6",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10689-010-9386-x",
      "author": "KI Aktan-Collan",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "journal-title": "Fam Cancer",
      "key": "89_CR24",
      "unstructured": "Aktan-Collan KI, Kääriäinen HA, Kolttola EM, Pylvänäinen K, Järvinen HJ, Haukkala AH et al (2011) Sharing genetic risk with next generation: mutation-positive parents’ communication with their offspring in Lynch Syndrome. Fam Cancer 10:43–50",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1023/A:1025864703405",
      "author": "TL Bodd",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "J Genet Couns",
      "key": "89_CR25",
      "unstructured": "Bodd TL, Reichelt J, Heimdal K, Møller P (2003) Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway. J Genet Couns 12:405–417",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201206",
      "author": "L Brooks",
      "doi-asserted-by": "publisher",
      "first-page": "654",
      "journal-title": "Eur J Hum Genet",
      "key": "89_CR26",
      "unstructured": "Brooks L, Lennard F, Shenton A, Lalloo F, Ambus I, Ardern-Jones A et al (2004) BRCA1/2 predictive testing: a study of uptake in two centres. Eur J Hum Genet 12:654–662",
      "volume": "12",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.2005.039172",
      "author": "GK Suthers",
      "doi-asserted-by": "publisher",
      "first-page": "665",
      "journal-title": "J Med Genet",
      "key": "89_CR27",
      "unstructured": "Suthers GK, Armstrong J, McCormack J, Trott D (2006) Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 43:665–670",
      "volume": "43",
      "year": "2006"
    },
    {
      "author": "N Cody",
      "first-page": "140",
      "journal-title": "Ir Med J",
      "key": "89_CR28",
      "unstructured": "Cody N, Green A, McDevitt T, Lynch SA (2008) Cascade screening in BRCA1/2 mutation carriers. Ir Med J 101:140–142",
      "volume": "101",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ejhg.2008.17",
      "author": "SM Holloway",
      "doi-asserted-by": "publisher",
      "first-page": "906",
      "journal-title": "Eur J Hum Genet",
      "key": "89_CR29",
      "unstructured": "Holloway SM, Bernhard B, Campbell H, Lam WW (2008) Uptake of testing for BRCA1/2 mutations in South East Scotland. Eur J Hum Genet 16:906–912",
      "volume": "16",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1399-0004.2008.01146.x",
      "author": "DGR Evans",
      "doi-asserted-by": "publisher",
      "first-page": "124",
      "journal-title": "Clin Genet",
      "key": "89_CR30",
      "unstructured": "Evans DGR, Binchy A, Shenton A, Hopwood P, Craufurd D (2009) Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives. Clin Genet 75:124–132",
      "volume": "75",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10689-009-9313-1",
      "author": "J Sanz",
      "doi-asserted-by": "publisher",
      "first-page": "297",
      "journal-title": "Fam Cancer",
      "key": "89_CR31",
      "unstructured": "Sanz J, Ramón y Cajal T, Torres A, Darder E, Gadea N, Velasco A et al (2010) Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain. Fam Cancer 9:297–304",
      "volume": "9",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10689-011-9420-7",
      "author": "S-Y Yoon",
      "doi-asserted-by": "publisher",
      "first-page": "199",
      "journal-title": "Fam Cancer",
      "key": "89_CR32",
      "unstructured": "Yoon S-Y, Thong M-K, Taib NAM, Yip C-H, Teo S-H (2011) Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Fam Cancer 10:199–205",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1399-0004.2011.01788.x",
      "author": "C Fischer",
      "doi-asserted-by": "publisher",
      "first-page": "478",
      "journal-title": "Clin Genet",
      "key": "89_CR33",
      "unstructured": "Fischer C, Engel C, Sutter C, Zachariae S, Schmutzler R, Meindl A et al (2012) BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families. Clin Genet 82:478–483",
      "volume": "82",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10689-015-9854-4",
      "author": "E Sermijn",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Fam Cancer",
      "key": "89_CR34",
      "unstructured": "Sermijn E, Delesie L, Deschepper E, Pauwels I, Bonduelle M, Teugels E et al (2016) The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety. Fam Cancer 15:155–162",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1136/jmg.2007.051581",
      "author": "K Aktan-Collan",
      "doi-asserted-by": "publisher",
      "first-page": "732",
      "journal-title": "J Med Genet",
      "key": "89_CR35",
      "unstructured": "Aktan-Collan K, Haukkala A, Pylvänäinen K, Järvinen HJ, Aaltonen LA, Peltomäki P et al (2007) Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet 44:732–738",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1399-0004.2007.00912.x",
      "author": "D Ramsoekh",
      "doi-asserted-by": "publisher",
      "first-page": "562",
      "journal-title": "Clin Genet",
      "key": "89_CR36",
      "unstructured": "Ramsoekh D, van Leerdam ME, Tops CMJ, Dooijes D, Steyerberg EW, Kuipers EJ et al (2007) The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP. Clin Genet 72:562–567",
      "volume": "72",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.pec.2013.02.001",
      "author": "Z Bruwer",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "journal-title": "Patient Educ Couns",
      "key": "89_CR37",
      "unstructured": "Bruwer Z, Futter M, Ramesar R (2013) Communicating cancer risk within an African context: experiences, disclosure patterns and uptake rates following genetic testing for Lynch syndrome. Patient Educ Couns 92:53–60",
      "volume": "92",
      "year": "2013"
    },
    {
      "DOI": "10.1111/cge.12559",
      "author": "P Barrow",
      "doi-asserted-by": "publisher",
      "first-page": "517",
      "journal-title": "Clin Genet",
      "key": "89_CR38",
      "unstructured": "Barrow P, Green K, Clancy T, Lalloo F, Hill J, Evans DG (2015) Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care study. Clin Genet 87:517–524",
      "volume": "87",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ejhg.2017.132",
      "author": "TT Seppälä",
      "doi-asserted-by": "publisher",
      "first-page": "1237",
      "journal-title": "Eur J Hum Genet",
      "key": "89_CR39",
      "unstructured": "Seppälä TT, Pylvänäinen K, Mecklin J-P (2017) Uptake of genetic testing by the children of Lynch syndrome variant carriers across three generations. Eur J Hum Genet 25:1237–1245",
      "volume": "25",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10689-016-9889-1",
      "author": "MB Daly",
      "doi-asserted-by": "publisher",
      "first-page": "697",
      "journal-title": "Fam Cancer",
      "key": "89_CR40",
      "unstructured": "Daly MB, Montgomery S, Bingler R, Ruth K (2016) Communicating genetic test results within the family: is it lost in translation? A survey of relatives in the randomized six-step study. Fam Cancer 15:697–706",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10689-015-9842-8",
      "author": "CHM Leenen",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "journal-title": "Fam Cancer",
      "key": "89_CR41",
      "unstructured": "Leenen CHM, den Heijer M, van der Meer C, Kuipers EJ, van Leerdam ME, Wagner A (2016) Genetic testing for Lynch syndrome: family communication and motivation. Fam Cancer 15:63–73",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10897-006-9053-4",
      "author": "KA Schneider",
      "doi-asserted-by": "publisher",
      "first-page": "491",
      "journal-title": "J Genet Couns",
      "key": "89_CR42",
      "unstructured": "Schneider KA, Chittenden AB, Branda KJ, Keenan MA, Joffe S, Patenaude AF et al (2006) Ethical issues in cancer genetics: 1) Whose information is it? J Genet Couns 15:491–503",
      "volume": "15",
      "year": "2006"
    },
    {
      "DOI": "10.1503/cmaj.070956",
      "author": "M Lacroix",
      "doi-asserted-by": "publisher",
      "first-page": "593",
      "journal-title": "CMAJ",
      "key": "89_CR43",
      "unstructured": "Lacroix M, Nycum G, Godard B, Knoppers BM (2008) Should physicians warn patients’ relatives of genetic risks? CMAJ 178:593–595",
      "volume": "178",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s12687-012-0132-y",
      "author": "L Black",
      "doi-asserted-by": "publisher",
      "first-page": "203",
      "journal-title": "J Community Genet",
      "key": "89_CR44",
      "unstructured": "Black L, McClellan KA, Avard D, Knoppers BM (2013) Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider. J Community Genet 4:203–214",
      "volume": "4",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10897-014-9805-5",
      "author": "R George",
      "doi-asserted-by": "publisher",
      "first-page": "388",
      "journal-title": "J Genet Couns",
      "key": "89_CR45",
      "unstructured": "George R, Kovak K, Cox SL (2015) Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases. J Genet Couns 24:388–399",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1111/bioe.12176",
      "author": "M Weaver",
      "doi-asserted-by": "publisher",
      "first-page": "181",
      "journal-title": "Bioethics",
      "key": "89_CR46",
      "unstructured": "Weaver M (2016) The double helix: applying an ethic of care to the duty to warn genetic relatives of genetic information. Bioethics 30:181–187",
      "volume": "30",
      "year": "2016"
    },
    {
      "DOI": "10.1177/0968533217721966",
      "author": "C Mitchell",
      "doi-asserted-by": "publisher",
      "first-page": "158",
      "journal-title": "Med Law Int",
      "key": "89_CR47",
      "unstructured": "Mitchell C, Ploem MC, Chico V, Ormondroyd E, Hall A, Wallace S et al (2017) Exploring the potential duty of care in clinical genomics under UK Law. Med Law Int 17:158–182",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1136/medethics-2015-102781",
      "author": "S Dheensa",
      "doi-asserted-by": "publisher",
      "first-page": "174",
      "journal-title": "J Med Ethics",
      "key": "89_CR48",
      "unstructured": "Dheensa S, Fenwick A, Lucassen A (2016) “Is this knowledge mine and nobody else’s? I don’t feel that.” Patient views about consent, confidentiality and information-sharing in genetic medicine. J Med Ethics 42:174–179",
      "volume": "42",
      "year": "2016"
    },
    {
      "author": "Committee on Genetics, American College of Obstetricians and Gynecologists",
      "first-page": "e96-e101",
      "journal-title": "Obstet Gynecol",
      "key": "89_CR49",
      "unstructured": "Committee on Genetics, American College of Obstetricians and Gynecologists (2017) Counseling about genetic testing and communication of genetic test results. Obstet Gynecol 129: e96-e101",
      "volume": "129",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41431-018-0103-9",
      "author": "D D’Audiffret Van Haecke",
      "doi-asserted-by": "publisher",
      "journal-title": "Eur J Hum Genet",
      "key": "89_CR50",
      "unstructured": "D’Audiffret Van Haecke D, de Montgolfier S (2018) Genetic diseases and information to relatives: practical and ethical issues for professionals after introduction of a legal framework in France. Eur J Hum Genet. \n                    https://doi.org/10.1038/s41431-018-0103-9",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2017.257",
      "author": "MA Rothstein",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Genet Med",
      "key": "89_CR51",
      "unstructured": "Rothstein MA (2018) Reconsidering the duty to warn genetically at-risk relatives. Genet Med 20:285–290",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41431-018-0138-y",
      "author": "M Parker",
      "doi-asserted-by": "publisher",
      "journal-title": "Eur J Hum Genet",
      "key": "89_CR52",
      "unstructured": "Parker M, Lucassen A (2018) Using a genetic test result in the care of family members: how does the duty of confidentiality apply? Eur J Hum Genet. \n                    https://doi.org/10.1038/s41431-018-0138-y",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10689-013-9609-z",
      "author": "SV Montgomery",
      "doi-asserted-by": "publisher",
      "first-page": "537",
      "journal-title": "Fam Cancer",
      "key": "89_CR53",
      "unstructured": "Montgomery SV, Barsevick AM, Egleston BL, Bingler R, Ruth K, Miller SM et al (2013) Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial. Fam Cancer 12:537–546",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1186/1745-6215-15-86",
      "author": "E Geus de",
      "doi-asserted-by": "publisher",
      "first-page": "86",
      "journal-title": "Trials",
      "key": "89_CR54",
      "unstructured": "Geus de E, Aalfs CM, Verdam MGE, de Haes HCJM, Smets EMA (2014) Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial. Trials 15:86",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ejhg.2015.122",
      "author": "J Hodgson",
      "doi-asserted-by": "publisher",
      "first-page": "356",
      "journal-title": "Eur J Hum Genet",
      "key": "89_CR55",
      "unstructured": "Hodgson J, Metcalfe S, Gaff C, Donath S, Delatycki MB, Winship I et al (2016) Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication. Eur J Hum Genet 24:356–360",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10689-010-9383-0",
      "author": "P Ratnayake",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Fam Cancer",
      "key": "89_CR56",
      "unstructured": "Ratnayake P, Wakefield CE, Meiser B, Suthers G, Price MA, Duffy J et al (2011) An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations. Fam Cancer 10:97–105",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1186/1897-4287-10-4",
      "author": "A Kardashian",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "89_CR57",
      "unstructured": "Kardashian A, Fehniger J, Creasman J, Cheung E, Beattie MS (2012) A pilot study of the sharing risk information tool (ShaRIT) for families with hereditary breast and ovarian cancer syndrome. Hered Cancer Clin Pract 10:4",
      "volume": "10",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10689-014-9720-9",
      "author": "K Dilzell",
      "doi-asserted-by": "publisher",
      "first-page": "381",
      "journal-title": "Fam Cancer",
      "key": "89_CR58",
      "unstructured": "Dilzell K, Kingham K, Ormond K, Ladabaum U (2014) Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives. Fam Cancer 13:381–389",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10897-017-0164-x",
      "author": "S Dheensa",
      "doi-asserted-by": "publisher",
      "first-page": "689",
      "journal-title": "J Genet Counsel",
      "key": "89_CR59",
      "unstructured": "Dheensa S, Lucassen A, Fenwick A (2018) Limitations and pitfalls of using family letters to communicate genetic risk: a qualitative study with patients and healthcare professionals. J Genet Couns 27:689–701",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1097/GIM.0b013e318164540b",
      "author": "LE Forrest",
      "doi-asserted-by": "publisher",
      "first-page": "167",
      "journal-title": "Genet Med",
      "key": "89_CR60",
      "unstructured": "Forrest LE, Burke J, Bacic S, Amor DJ (2008) Increased genetic counseling support improves communication of information in families. Genet Med 10:167–172",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1038/nrgastro.2013.122",
      "author": "K Jasperson",
      "doi-asserted-by": "publisher",
      "first-page": "506",
      "journal-title": "Nat Rev Gastroenterol Hepatol",
      "key": "89_CR61",
      "unstructured": "Jasperson K (2013) Cascade genetic testing in Lynch syndrome: room for improvement. Nat Rev Gastroenterol Hepatol 10:506–508",
      "volume": "10",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10689-016-9893-5",
      "author": "H Hampel",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "journal-title": "Fam Cancer",
      "key": "89_CR62",
      "unstructured": "Hampel H (2016) Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer 15:423–427",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ejhg.2015.174",
      "author": "A Mendes",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "journal-title": "Eur J Hum Genet",
      "key": "89_CR63",
      "unstructured": "Mendes A, Paneque M, Sousa L, Clarke A, Sequeiros J et al (2016) How communication of genetic information within the family is addressed in genetic counselling: a systematic review of research evidence. Eur J Hum Genet 24:315–325",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.2196/resprot.8138",
      "author": "MC Katapodi",
      "doi-asserted-by": "publisher",
      "first-page": "e184",
      "journal-title": "JMIR Res Protoc",
      "key": "89_CR64",
      "unstructured": "Katapodi MC, Viassolo V, Caiata-Zufferey M, Nikolaidis C, Bührer-Landolt R, Buerki N et al (2017) Cancer predisposition cascade screening for hereditary breast/ovarian cancer and Lynch syndromes in Switzerland: study protocol. JMIR Res Protoc 6:e184",
      "volume": "6",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nrclinonc.2016.90",
      "author": "N Tung",
      "doi-asserted-by": "publisher",
      "first-page": "581",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "89_CR65",
      "unstructured": "Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber JE et al (2016) Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol 13:581–588",
      "volume": "13",
      "year": "2016"
    },
    {
      "DOI": "10.1097/GIM.0b013e318204cfed",
      "author": "J Vos",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "journal-title": "Genet Med",
      "key": "89_CR66",
      "unstructured": "Vos J, Jansen AM, Menko F, van Asperen CJ, Stiggelbout AM, Tibben A (2011) Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results. Genet Med 13:333–341",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1136/jmedgenet-2012-100961",
      "author": "S Moghadasi",
      "doi-asserted-by": "publisher",
      "first-page": "74",
      "journal-title": "J Med Genet",
      "key": "89_CR67",
      "unstructured": "Moghadasi S, Hofland N, Wouts JN, Hogervorst FBL, Wijnen JT, Vreeswijk MPG et al (2013) Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling. J Med Genet 50:74–79",
      "volume": "50",
      "year": "2013"
    },
    {
      "DOI": "10.1002/ijc.29128",
      "author": "DVT Catenacci",
      "doi-asserted-by": "publisher",
      "first-page": "1559",
      "journal-title": "Int J Cancer",
      "key": "89_CR68",
      "unstructured": "Catenacci DVT, Amico AL, Nielsen SM, Geynisman DM, Rambo B, Carey GB et al (2015) Tumor genome analysis includes germline genome: are we ready for surprises? Int J Cancer 136:1559–1567",
      "volume": "136",
      "year": "2015"
    },
    {
      "DOI": "10.1200/JCO.2014.56.2728",
      "author": "B Kaufman",
      "doi-asserted-by": "publisher",
      "first-page": "244",
      "journal-title": "J Clin Oncol",
      "key": "89_CR69",
      "unstructured": "Kaufman B, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmaňa J et al (2015) Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J Clin Oncol 33:244–250",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ygyno.2017.05.037",
      "author": "EM Bednar",
      "doi-asserted-by": "publisher",
      "first-page": "399",
      "journal-title": "Gynecol Oncol",
      "key": "89_CR70",
      "unstructured": "Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN et al (2017) A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment. Gynecol Oncol 146:399–404",
      "volume": "146",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jama.2017.11137",
      "author": "D Mandelker",
      "doi-asserted-by": "publisher",
      "first-page": "825",
      "journal-title": "JAMA",
      "key": "89_CR71",
      "unstructured": "Mandelker D, Zhang L, Kemel Y, Stadler ZK, Joseph V, Zehir A et al (2017) Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing. JAMA 318:825–835",
      "volume": "318",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2017.75.8490",
      "author": "S Narod",
      "doi-asserted-by": "publisher",
      "first-page": "517",
      "journal-title": "J Clin Oncol",
      "key": "89_CR72",
      "unstructured": "Narod S, Akbari MR (2018) Population-based genetic testing for BRCA1 and BRCA2. J Clin Oncol 36:517",
      "volume": "36",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2015.60.9388",
      "author": "LE Forrest",
      "doi-asserted-by": "publisher",
      "first-page": "898",
      "journal-title": "J Clin Oncol",
      "key": "89_CR73",
      "unstructured": "Forrest LE, Young M-A (2016) Clinically significant germline mutations in cancer-causing genes identified through research studies should be offered to research participants by genetic counselors. J Clin Oncol 34:898–901",
      "volume": "34",
      "year": "2016"
    }
  ],
  "reference-count": 73,
  "references-count": 73,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-018-0089-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}